Device type · JWY
Manual Antimicrobial Susceptibility Test Systems
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
JWY
Microbiology
Device class
Class II
FDA decisions since 2015
96
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Manual Antimicrobial Susceptibility Test Systems
- Product code
- JWY
- Device class
- Class II
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.1640
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JWY
Latest FDA decisions
The 8 newest of 96 since 2015.
K260447 · Decided Apr 21, 2026 · 69 days after receipt
Device type: Manual Antimicrobial Susceptibility Test Systems (JWY) · Laboratory Medicine & Pathology
K260696 · Decided Apr 17, 2026 · 45 days after receipt
Device type: Manual Antimicrobial Susceptibility Test Systems (JWY) · Laboratory Medicine & Pathology
K252114 · Decided Oct 2, 2025 · 87 days after receipt
Device type: Manual Antimicrobial Susceptibility Test Systems (JWY) · Laboratory Medicine & Pathology
93 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Thermo SCIENTIFIC Sensititre Cation Adjusted AutoRead Mueller-Hinton Broth w/ TES w/ Lysed Horse Blood, REF CP11410; invitro diagnostic deviceOpen, Classified
Z-1947-2025 · Started May 1, 2025 · Posted by FDA Jun 11, 2025
Reason given: Product may have an off color affecting perfomance
Cause as FDA categorized it: Under Investigation by firm
- ETEST CLINICAL AMIKACIN AK 256 US S30, CATALOG 412218Open, Classified
Z-0817-2023 · Started Nov 9, 2022 · Posted by FDA Jan 4, 2023
Reason given: As the temperature and time out of range was exceeded, product performances cannot be guaranteed
Cause as FDA categorized it: Storage
- ETEST CLINICAL AMOXI/CLAV 2/1 XL 256 US S30, CATALOG 412240Open, Classified
Z-0818-2023 · Started Nov 9, 2022 · Posted by FDA Jan 4, 2023
Reason given: As the temperature and time out of range was exceeded, product performances cannot be guaranteed
Cause as FDA categorized it: Storage
75 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.